Predicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai Zhongshan Hospital
About this trial
The aim of this study was to identify and validate novel biomarkers for predict acute kidney injury (AKI) subphenotype, major adverse kidney events and other poor outcomes.
Eligibility criteria
Qualifiers
Patients undergoing cardiac surgery who experienced AKI within 48 hours of cardiac surgery were screened.
Disqualifiers
History of End Stage Renal Disease or on Dialysis;
prior kidney transplantation;
patients with a DNR order;
patients without written informed consent;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Shanghai Zhongshan Hospital
Lead sponsor
Zhongshan Hospital (Xiamen), Fudan University
Collaborator
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Collaborator
Source ClinicalTrials.gov